Details for Patent: 7,960,424
✉ Email this page to a colleague
Which drugs does patent 7,960,424 protect, and when does it expire?
Patent 7,960,424 protects ALOXI and is included in one NDA.
Protection for ALOXI has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-three patent family members in forty countries.
Summary for Patent: 7,960,424
| Title: | Liquid pharmaceutical formulations of palonosetron |
| Abstract: | The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments. |
| Inventor(s): | Calderari; Giorgio (Rancate, CH), Bonadeo; Daniele (Varese, IT), Cannella; Roberta (Varese, IT), Braglia; Enrico (Pazzallo, CH), Braglia; Riccardo (Pazzallo, CH), Miksztal; Andrew (Palo Alto, CA), Malefyt; Thomas (Carmel Valley, CA), Lee; Kathleen M. (Palo Alto, CA) |
| Assignee: | Helsinn Healthcare S.A. (Lugano, CH) Roche Palo Alto LLC (Palo Alto, CA) |
| Application Number: | 11/388,270 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,960,424 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 7,960,424
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,960,424
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 2110 | ⤷ Sign Up | |||
| Argentina | 042977 | ⤷ Sign Up | |||
| Austria | 410167 | ⤷ Sign Up | |||
| Australia | 2004208505 | ⤷ Sign Up | |||
| Brazil | PI0407121 | ⤷ Sign Up | |||
| Canada | 2514224 | ⤷ Sign Up | |||
| Canada | 2573194 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
